The blanking interval after atrial fibrillation ablation: time for reassessment with pulsed field energy

Read full text
Authors: Juan F. Rodriguez, Hema Srikanth Vemulapalli, James Y. Kim, Luis R. Scott, Arturo M. Valverde, Mayank Sardana, Abhishek Deshmukh, Suraj Kapa, Christopher J. McLeod, Komandoor Srivathsan
Cited by: 2
References: 22

Abstract

AIMS: The clinical significance of early recurrences during the blanking period following pulmonary vein isolation (PVI) remains uncertain, particularly after pulsed field ablation (PFA). This study aimed to evaluate the prognostic impact of early recurrences at 30-, 60-, and 90-day thresholds on outcomes following PFA for atrial fibrillation (AF). METHODS AND RESULTS: Consecutive patients who underwent PFA for AF across multiple centres within the Mayo Clinic health system were included. The primary endpoint was AF-free survival. Kaplan-Meier and multivariate Cox regression analyses were performed to compare outcomes between patients with and without early recurrences using 30-, 60-, and 90-day thresholds. A total of 1162 patients were included. The estimated AF-free survival at 1 year was 70%. Early recurrences within 30-, 60-, and 90-days post-ablation were significantly associated with late recurrences beyond 90 days (hazard ratio [HR] 5.9, 95% confidence interval [CI] 4.4-7.9, P < 0.01; HR 6.6, 95% CI: 5.0-8.6, P < 0.01; and HR 9.1, 95% CI: 7.0-11.7, P < 0.01, respectively). These findings remained significant among patients undergoing continuous rhythm monitoring. Early recurrences within 30 days in this subgroup were significantly associated with a 1-year AF burden >1% or the need for repeat AF ablation (odds ratio 25.0, 95% CI: 6.6-126.8, P < 0.01). CONCLUSION: Early recurrences following PFA are strongly predictive of long-term arrhythmia recurrence and are unlikely to represent transient inflammatory phenomena. Accordingly, the applicability of the conventional blanking interval after PFA should be reconsidered.

Fields of Study & Subjects

Atrial Fibrillation Management and Outcomes Cardiac Arrhythmias and Treatments Cardiovascular Disease and Adiposity

Publication details

Journal / source
EP Europace
Publisher
Oxford University Press (OUP)
Volume
28
Issue
3
Publication date
1 March 2026
Language
EN